Melanoma-secreted amyloid beta suppresses neuroinflammation and promotes brain metastasis Journal Article


Authors: Kleffman, K.; Levinson, G.; Rose, I. V. L.; Blumenberg, L. M.; Shadaloey, S. A. A.; Dhabaria, A.; Wong, E.; Galán-Echevarría, F.; Karz, A.; Argibay, D.; Von Itter, R.; Floristán, A.; Baptiste, G.; Eskow, N. M.; Tranos, J. A.; Chen, J.; Vega y Saenz de Miera, E. C.; Call, M.; Rogers, R.; Jour, G.; Wadghiri, Y. Z.; Osman, I.; Li, Y. M.; Mathews, P.; DeMattos, R. B.; Ueberheide, B.; Ruggles, K. V.; Liddelow, S. A.; Schneider, R. J.; Hernando, E.
Article Title: Melanoma-secreted amyloid beta suppresses neuroinflammation and promotes brain metastasis
Abstract: Brain metastasis is a significant cause of morbidity and mortality in multiple cancer types and represents an unmet clinical need. The mechanisms that mediate metastatic cancer growth in the brain parenchyma are largely unknown. Melanoma, which has the highest rate of brain metastasis among common cancer types, is an ideal model to study how cancer cells adapt to the brain parenchyma. Our unbiased proteomics analysis of melanoma short-term cultures revealed that proteins implicated in neurodegenerative pathologies are differentially expressed in melanoma cells explanted from brain metastases compared with those derived from extracranial metastases. We showed that melanoma cells require amyloid beta (Aβ) for growth and survival in the brain parenchyma. Melanoma-secreted Aβ activates surrounding astrocytes to a prometastatic, anti-inflammatory phenotype and prevents phagocytosis of melanoma by microglia. Finally, we demonstrate that pharmacologic inhibition of Aβ decreases brain metastatic burden. SIGNIFICANCE: Our results reveal a novel mechanistic connection between brain metastasis and Alzheimer’s disease, two previously unrelated pathologies; establish Aβ as a promising therapeutic target for brain metastasis; and demonstrate suppression of neuroinflammation as a critical feature of metastatic adaptation to the brain parenchyma. © 2022 American Association for Cancer Research.
Keywords: immunohistochemistry; cancer survival; controlled study; human tissue; protein expression; human cell; genetics; nonhuman; nuclear magnetic resonance imaging; brain tumor; brain neoplasms; binding affinity; cell proliferation; mass spectrometry; mouse; metabolism; animal tissue; melanoma; metastasis; apoptosis; gene expression; confocal microscopy; image analysis; tumor volume; animal experiment; animal model; astrocyte; immunofluorescence; proteomics; enzyme linked immunosorbent assay; amino acid sequence; genetic transfection; cell culture; western blotting; brain metastasis; neoplasm metastasis; melanoma cell; immunoblotting; real time polymerase chain reaction; gene silencing; phagocytosis; tubulin; oxygen consumption; oxidative phosphorylation; alzheimer disease; cd45ra antigen; astrocytes; rna sequence; secretase; nerve degeneration; metabolic activation; parenchyma; rna analysis; beta actin; transmission electron microscopy; amyloid beta protein; rna isolation; nervous system inflammation; liquid chromatography-mass spectrometry; choroid plexus; machine learning; amyloid beta-peptides; tumor spheroid; astrocytosis; disease burden; humans; human; article; lentivirus infection; gene editing; crispr-cas9 system; hek293t cell line; brain ­to­ body luminescence ratio; tmt labeling; neuroinflammatory diseases
Journal Title: Cancer Discovery
Volume: 12
Issue: 5
ISSN: 2159-8274
Publisher: American Association for Cancer Research  
Date Published: 2022-05-01
Start Page: 1314
End Page: 1335
Language: English
DOI: 10.1158/2159-8290.Cd-21-1006
PUBMED: 35262173
PROVIDER: scopus
PMCID: PMC9069488
DOI/URL:
Notes: Article -- Export Date: 1 June 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yueming Li
    132 Li
  2. Wan Fung Wong
    12 Wong